Skip to content

Eosinophilic esophagitis treatment trial

Dysphagia

A clinical research study to evaluating the safety and tolerability of 2 mg once daily vs. 1 mg twice daily budesonide orodispersible tablets in study participants with eosinophilic
esophagitis

null

Conditions de participation

  • Sexe:

    Male, Female

  • Âges admissibles:

    18 to 75

Critères de participation

Inclusion Criteria:
You may be eligible to participate in this trial if you are:
- between the age of 18 to 75 years
- have been diagnosed with eosinophilic esophagitis

Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion Criteria:
You may not be eligible to participate in this trial if you:

- have gastroesophageal reflux disease (GERD), Achalasia, sclerosis
- female who is breast feeding or pregnant

Doctors will also evaluate other criteria to make sure you qualify for the study.

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB22-0539